Latest News and Press Releases

JERSEY, Channel Islands, June 24, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (Nasdaq: QTNT) (the Company), a commercial-stage diagnostics company, today announced the pricing of an underwritten...

Financial Position Amended Secured Notes: Reduces the company’s cash obligations by approximately $93 million over the next 36 monthsAnnounces Public Equity Offering: Improving liquidity runwayFY...

JERSEY, Channel Islands, June 23, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (Nasdaq: QTNT) (the Company), a commercial-stage diagnostics company, today announced that in connection with the public...

JERSEY, Channel Islands, June 23, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (Nasdaq: QTNT) (the Company), a commercial-stage diagnostics company, today announced the Company intends to commence an...

Pre-announces FY 2022 revenue of $38.5 millionSecured $1.4 million of orders in Q1 FY23 for recently CE Marked Extended IH MosaiQ Solution$83.2 million in cash and investments as of March 31, 2022 ...

JERSEY, Channel Islands, June 17, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal fourth...

Partnership brings together novel technology and clinical applications expertise to produce automated, multiplexed solutions for advancing autoimmune diagnosticsExpands access to $2 billion autoimmune...

Diversified global presence key to Company's go-to-market strategyStrengthened geographical expansion with distributor strategy model to better support customers in the region JERSEY, Channel...

Virtual event on Monday, May 23rd at 11:00 AM ETThe webinar will provide a detailed discussion on the current landscape and unmetneeds within blood grouping and donor disease screening JERSEY,...

JERSEY, Channel Islands, April 26, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced the appointment of Thomas Aebischer to Quotient...